AI Analysis

How does 323990.KQ make money? Does 323990.KQ have pricing power? What's the Earnings Whisper? Will 323990.KQ profit more as the business scales? What is 323990.KQ's management track record? Is 323990.KQ's current price justified?

Vaxcell-Bio Therapeutics Co., Ltd.

₩4110 -$5910.00 (-58.98%)

KOE · 16 Oct 2026 06:30 UTC

Previous Close

₩3890

Day Range

₩3900₩4350

Year Range

₩3350₩11520

Market Cap

95.24B

AVG Volume

166.35K

Trailing/Forward PE

-6.39/-

PEG ratio

0.34

Dividend Yield

Next Earnings Date

Primary Exchange

KOSDAQ

Revenue (KRW) · TTM

323990.KQ Revenue (KRW) by quarter, trailing twelve months
Period	Revenue (KRW)
26 Q2	6.51B
26 Q1	6.87B
25 Q4	7.06B
25 Q3	6.72B
25 Q2	5.55B
25 Q1	3.59B
24 Q4	1.9B
24 Q3	552.48M
24 Q2	69.6M
24 Q1	40.36M

Net Income (KRW) · TTM

323990.KQ Net Income (KRW) by quarter, trailing twelve months
Period	Net Income (KRW)
26 Q2	-14.92B
26 Q1	-14.69B
25 Q4	-13.34B
25 Q3	-12.44B
25 Q2	-12.17B
25 Q1	-10.79B
24 Q4	-10.62B
24 Q3	-10.03B
24 Q2	-10.43B
24 Q1	-10.48B

Operating Income (KRW) · TTM

323990.KQ Operating Income (KRW) by quarter, trailing twelve months
Period	Operating Income (KRW)
26 Q2	-16.82B
26 Q1	-15.91B
25 Q4	-15.59B
25 Q3	-16.2B
25 Q2	-16.29B
25 Q1	-16.1B
24 Q4	-15.04B
24 Q3	-13.83B
24 Q2	-13.39B
24 Q1	-12.25B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (KRW) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Vaxcell-Bio Therapeutics Co., Ltd.

Video analysis: 323990.KQ

News: 323990.KQ

Similar companies